Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,679 annual reports · 4,010 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 40 of 640 · 7,679 filings

  • Vivakor (VIVK) FY2025 10-K risk factors
    47 risks21 new22 dropped17 reworded

    Vivakor faces heavy operational dependence on local oil and gas exploration and production activity, particularly in the Permian and Eagle Ford Basins.

    Filed Apr 15, 2026
  • Versus Systems (VS) FY2025 10-K risk factors
    43 risks3 new2 dropped4 reworded

    Revenue concentration and financial stability are major risks following customer loss.

    Filed Apr 15, 2026
  • Vivos Therapeutics (VVOS) FY2025 10-K risk factors
    47 risks8 new4 dropped6 reworded

    Vivos expanded its business model through the SCN acquisition, financing it with an $8.25 million Streeterville note and significant equity issuance.

    Filed Apr 15, 2026
  • XCel Brands (XELB) FY2025 10-K risk factors
    42 risks4 new6 dropped11 reworded

    Senior secured notes totaling $3.01 million issued in April 2026 threaten liquidity and operational flexibility. Concentration risks shifted as G-III Apparel Group Halston Master License grew to 52% of revenue while Qurate dropped to 20%. Ongoing going concern doubts persist due to historical net losses and cash usage.

    Filed Apr 15, 2026
  • XMax (XMAX) FY2025 10-K risk factors
    27 risks5 dropped8 reworded

    XMax expanded its authorized common stock from 250 million to 5 billion shares, highlighting dilution and capital raising risks.

    Filed Apr 15, 2026
  • XTI Aerospace (XTIA) FY2025 10-K risk factors
    78 risks49 new26 dropped13 reworded

    XTI Aerospace pivoted toward unmanned aerial systems distribution and services through Drone Nerds, while pausing the TriFan 600 program.

    Filed Apr 15, 2026
  • LQR House (YHC) FY2025 10-K risk factors
    52 risks6 new3 dropped2 reworded

    The company faces severe going concern doubts, relying entirely on CWS for alcohol distribution while expanding into high-risk new ventures like digital assets, securities brokerage, and a proposed SWOL IPO.

    Filed Apr 15, 2026
  • BioNexus Gene Lab (BGLC) FY2025 10-K risk factors
    50 risks3 dropped4 reworded

    BioNexus dropped cryptocurrency exploration and Chemrex governance transaction risks while updating exposures to Malaysian regulation, economic cycles, and biotech competition.

    Filed Apr 14, 2026
  • Blue Water Acquisition Corp. III (BLUW) FY2025 10-K risk factors
    76 risks

    Blue Water Acquisition Corp. III is a special purpose acquisition company searching for an initial business combination target. The company faces specific risks related to redemption rights, sponsor changes, and working capital debt. Potential targets may be early-stage or privately held companies with limited financial information.

    Filed Apr 14, 2026
  • Data Storage (DTST) FY2025 10-K risk factors
    32 risks10 new14 dropped19 reworded

    Divestiture of the CloudFirst business leaves the company seeking new strategic directions and potential acquisitions using $9.6 million in cash.

    Filed Apr 14, 2026
  • Triller Group (ILLR) FY2025 10-K risk factors
    92 risks

    Triller Group faces extensive litigation and liquidity pressures alongside defaults on music licensing agreements. Operations depend heavily on brand advertising revenue, creator retention, and mobile platform interoperability. Regulatory risks stem from Hong Kong operations, PRC proximity, and data protection compliance.

    Filed Apr 14, 2026
  • Ip Strategy Holdings (IPST) FY2025 10-K risk factors
    123 risks49 new20 dropped14 reworded

    The company has shifted its primary business focus toward crypto assets, specifically accumulating $IP Tokens and running validator operations. Financial results and stock price are now heavily exposed to extreme volatility in the cryptocurrency market. Net operating loss carryforwards are subject to strict annual limitations under Section 382 following equity issuances.

    Filed Apr 14, 2026

Companies covered

4,010 companies

371 more under A